High-dose antioxidants for central serous chorioretinopathy; The randomized placebo-controlled study

Abstract

The high-dose antioxidants for acute CSC did not show any benefits in VA and CMT. However, the drugs might decrease the chance for fluorescein leakage and additional treatments at the end of the 3rd month.